No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs6981540 |
chr8:1907855-1907856 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers Strong transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs538171565 |
chr8:1907856-1907857 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs137951165 |
chr8:1907869-1907870 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs377765598 |
chr8:1907873-1907874 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs545297896 |
chr8:1907904-1907905 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs193261491 |
chr8:1907931-1907932 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs7006457 |
chr8:1907935-1907936 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers Strong transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs541098890 |
chr8:1907956-1907957 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs560866251 |
chr8:1907962-1907963 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs13272508 |
chr8:1907973-1907974 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers Strong transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
11 |
rs373301177 |
chr8:1907982-1907983 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs116613510 |
chr8:1908006-1908007 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs569635064 |
chr8:1908015-1908016 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs76146413 |
chr8:1908030-1908031 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs539116697 |
chr8:1908051-1908052 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs13281187 |
chr8:1908052-1908053 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
17 |
rs565862437 |
chr8:1908071-1908072 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs572892956 |
chr8:1908084-1908085 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs375494818 |
chr8:1908138-1908139 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs547862168 |
chr8:1908174-1908175 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs138962288 |
chr8:1908184-1908185 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs536755832 |
chr8:1908221-1908222 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs76266622 |
chr8:1908228-1908229 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs114112935 |
chr8:1908231-1908232 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs142187625 |
chr8:1908242-1908243 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs558850184 |
chr8:1908301-1908302 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs528731317 |
chr8:1908302-1908303 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs572302467 |
chr8:1908305-1908306 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs541303203 |
chr8:1908330-1908331 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs561539510 |
chr8:1908345-1908346 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs146209374 |
chr8:1908385-1908386 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs575575490 |
chr8:1908390-1908391 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs386720726 |
chr8:1908391-1908392 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs115009195 |
chr8:1908393-1908394 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs78666178 |
chr8:1908408-1908409 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs377018652 |
chr8:1908416-1908417 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs552500221 |
chr8:1908447-1908448 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs559728284 |
chr8:1908453-1908454 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs528398457 |
chr8:1908460-1908461 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs548035081 |
chr8:1908475-1908476 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs13271878 |
chr8:1908476-1908477 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
42 |
rs372960273 |
chr8:1908484-1908485 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs566473661 |
chr8:1908502-1908503 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs139167459 |
chr8:1908503-1908504 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs535520303 |
chr8:1908508-1908509 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs74532697 |
chr8:1908511-1908512 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs202044478 |
chr8:1908575-1908576 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs60098078 |
chr8:1908592-1908593 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
49 |
rs141690483 |
chr8:1908616-1908617 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs558814704 |
chr8:1908635-1908636 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|